Background
Indwelling urinary catheters (UC) are an integral part of medicine today[
1,
2], and as many as one-quarter of all patients require their placement during hospital stay[
3]. Exposure to UC is currently considered the most important risk factor for healthcare-associated urinary tract infection (UTI) and is associated with significant morbidity[
3‐
5] and substantial extra-costs[
6,
7]. The literature suggests that the rate of UTI acquisition is 5% per day of UC use[
3]. Despite the harm potential and the existence of educational programmes to prevent unnecessary catheterisation, UC continues to be frequently used or maintained without clear indications[
3,
4,
8].
In Switzerland, nationwide period prevalence surveys of healthcare-associated infections have been regularly conducted for the past 15 years and provide a unique opportunity to gain insight into their epidemiology[
9‐
12]. During the 2004 survey, we collected additional data on exposure to UC and evaluated factors associated with UTI among hospitalised adult patients exposed and non-exposed to UC.
Results
A total of 8169 patients from 49 hospitals participated in the survey, representing a nationwide estimate of at least 30% of all hospitalised patients; 4313 (52.8%) were female[
12]. Among these, 1917 (23.5%) were exposed to UC with an overall median duration of use of 4 days (interquartile range, 2–9 days). Of 126 patients overall who developed UTI (1.5%; 85 female; median age, 77 years), 73 (58%) had been exposed to UC within the week preceding UTI onset, while 53 (42%) had no exposure. Sixty-two percent of all case report forms for UTI patients were maximally rated (6/6 points on the Likert scale) by observers and a further 25% with almost complete agreement (5/6 points). Females were at higher risk for UTI (odds ratio [OR], 2.1 [95% confidence interval (CI), 1.4-3.1]). Four UTI episodes were classified as upper UTI or abscesses, and six were bacteraemic. We identified a total of 14 different causative pathogens, of which the most frequent in descending order were
Escherichia coli,
Proteus spp,
Klebsiella spp,
Enterobacter spp, and
Enterococcus spp. On average, UTI was diagnosed 16 days after admission (range, 2 to 124 d). Patient population characteristics stratified according to the occurrence of UTI are shown in Table
1. The 38 episodes of asymptomatic urinary tract bacterial colonization were excluded according to our study protocol.
Table 1
Patient characteristics according to the presence of healthcare-associated urinary tract infection (UTI) (n = 8169),
Swiss-NOSO
Nationwide Prevalence Study, 2004
Urinary catheter exposure (%) | | |
<0.001
|
Yes | 73 (57.9) | 1912 (23.8) | |
No | 53 (42.1) | 6131 (76.2) | |
Gender, female (%) | 85 (67.5) | 4228 (52.6) |
0.001
|
Mean age (±SD) | 71.8 (15.6) | 62.4 (19.0) |
<0.001
|
Age groups (%) | | |
<0.001
|
<40 years | 7 (5.7) | 1395 (17.9) | |
41-70 years | 37 (30.3) | 3208 (41.2) | |
> = 71 years | 78 (63.9) | 3184 (40.9) | |
Hospital size | | | 0.09 |
<200 acute care beds | 23 (18.3) | 1994 (24.8) | |
200-500 beds | 40 (31.8) | 2748 (34.2) | |
> = 501 beds | 63 (50.0) | 3301 (41.0) | |
Mean length of stay (±SD) | 20.5(22.2) | 11.4 (41.0) |
<0.001*
|
Length of stay | | |
<0.001
|
<20 days | 89 (70.6) | 6990 (86.9) | |
21-40 days | 22 (17.5) | 677 (8.4) | |
> = 41 days | 15 (11.9) | 374 (4.7) | |
Recent stay in intensive care (%) | 34 (27.0) | 1030 (12.8) |
<0.001
|
Hospitalisation ward (%) | | |
0.003*
|
Medical ward | 45 (35.7) | 3192 (39.7) | |
Surgical ward | 50 (39.7) | 3219 (40.0) | |
Gynaecology/obstetrics | 5 (4.0) | 778 (9.7) | |
Intensive care unit | 7 (5.6) | 285 (3.5) | |
Medico-surgical | 19 (15.1) | 569 (7.1) | |
Recent surgery (%) | 61 (48.4) | 3292 (40.9) | 0.09 |
Mean ASA score (±SD) | 2.81 (0.67) | 2.33 (0.89) |
<0.001*
|
ASA (%) | | |
<0.001*
|
1 pt | 4 (3.2) | 1587 (19.8) | |
2-3 pts | 109 (87.2) | 5802 (72.3) | |
4-5 pts | 12 (9.6) | 634 (7.9) | |
McCabe/Jackson (%) | | |
0.01*
|
Non fatal | 82 (65.1) | 6143 (76.4) | |
Fatal within 5 years | 36 (28.6) | 1455 (18.1) | |
Fatal within 6 months | 8 (6.4) | 445 (5.5) | |
Mean nursing workload (±SD) | 204.0 (161.4) | 168.3 (162.8) |
0.008*
|
Mean Charlson index (±SD) | 1.8 (2.1) | 1.2 (1.8) |
<0.001*
|
Charlson group (%) | | |
0.02
|
0-3 pts | 106 (84.1) | 7267 (90.4) | |
> = 4 pts | 20 (15.9) | 776 (9.7) | |
Co-morbidities (%) | | | |
Diabetes mellitus | 19 (15.1) | 1074 (13.4) | 0.57 |
Immune suppression° | 26 (20.6) | 1047 (13.0) |
0.01
|
Hemiplegia | 24 (19.1) | 777 (9.7) |
<0.001
|
Dementia | 9 (7.1) | 290 (3.6) |
0.04
|
Multivariate adjustment
Overall UTI
By multivariate logistic regression analysis with a random effect at the hospital level, independent factors associated with higher odds for UTI were prior exposure to UC (odds ratio, OR, 3.9 [95% CI, 2.6-5.9]), female gender (OR, 2.1 [95% CI, 1.4-3.1]), ASA score of > 2 points (OR, 3.2 [95% CI, 1.1-9.4], and prolonged hospital stay > 20 days (OR, 1.9 [95% CI, 1.4-3.2]. When female gender and prior exposure were combined with UC as one risk factor, the likelihood of UTI increased by 10.4-fold compared to the combination of male gender and no prior exposure to UC. Women not exposed to UC had a 3.4-fold risk of UTI compared to men not exposed to UC. The likelihood of UTI increased independently with age, ASA group, and the length of hospital stay, after adjustment on the main other confounders (Tables
2 &
3).
Table 2
Multivariate logistic regression models clustered on hospitals presenting independent factors associated with urinary tract infection stratified on prior exposure to urinary catheter,
Swiss-NOSO
Nationwide Prevalence Study, 2004
Age groups (%) | | | 0.62 | | |
0.03*
|
<40 years | 1.00 | - | - | 1.00 | - | - |
41-70 years | 1.77 | 0.51-6.10 | 0.36 | 1.03 | 0.31-3.45 | 0.96 |
> = 71 years | 1.84 | 0.54-6.26 | 0.33 | 2.53 | 0.81-7.94 | 0.11 |
Recent surgical intervention | | | 0.75 | | | 0.59 |
No | 1.00 | - | | 1.00 | - | |
Yes | 0.92 | 0.54-1.56 | | 0.84 | 0.44-1.59 | |
ASA score (%) | | |
0.09*
| | | 0.39 |
1 pt | 1.00 | - | - | 1.00 | - | - |
2-3 pts | 7.21 | 0.96-54.35 | 0.06 | 1.99 | 0.54-7.28 | 0.30 |
4-5 pts | 4.52 | 0.51-39.74 | 0.17 | 1.11 | 0.18-6.78 | 0.91 |
Charlson group | | | 0.55 | | | 0.76 |
0-3 pts | 1.00 | - | | 1.00 | - | |
> = 4 pts | 1.30 | 0.55-3.08 | | 0.85 | 0.30-2.40 | |
Length of stay | | |
0.01*
| | |
0.09*
|
<20 days | 1.00 | - | - | 1.00 | - | - |
21-40 days | 1.88 | 0.92-3.85 | 0.08 | 2.01 | 0.95-4.22 | 0.07 |
> = 41 days | 2.87 | 1.34-6.11 | 0.006 | 2.12 | 0.84-5.35 | 0.11 |
Recent stay in intensive care | | | 0.99 | | |
0.05*
|
No | 1.00 | - | | 1.00 | - | |
Yes | 1.00 | 0.58-1.73 | | 2.30 | 1.01-5.20 | |
McCabe/Jackson (%) | | | 0.95 | | | 0.18 |
Non fatal | 1.00 | - | - | 1.00 | - | - |
Fatal within 5 years | 0.98 | 0.54-1.77 | 0.95 | 1.71 | 0.88-3.31 | 0.11 |
Fatal within 6 months | 1.15 | 0.45-2.93 | 0.76 | 0.50 | 0.06-3.87 | 0.50 |
Gender | | |
0.06*
| | |
0.001*
|
Male | 1.00 | - | | 1.00 | - | |
Female | 1.61 | 0.98-2.65 | | 3.27 | 1.65-6.48 | |
Hemiplegia | | | 0.78 | | |
0.03*
|
No | 1.00 | - | | 1.00 | - | |
Yes | 1.10 | 0.55-2.20 | | 2.10 | 1.07-4.11 | |
Immune suppression° | | | 0.67 | | | 0.45 |
No | 1.00 | - | | 1.00 | - | |
Yes | 1.18 | 0.54-2.58 | | 1.42 | 0.57-3.51 | |
Table 3
Multivariate logistic regression models clustered on hospitals presenting independent factors associated with urinary tract infection stratified on gender,
Swiss-NOSO
Nationwide Prevalence Study, 2004
Age groups (%) | | |
0.01*
| | |
0.10*
|
<70 years | 1.00 | - | | 1.00 | - | - |
> = 71 years | 2.57 | 1.24-5.31 | | 1.51 | 0.93-2.45 | |
Recent surgical intervention | | | 0.78 | | | 0.43 |
No | 1.00 | - | | 1.00 | - | |
Yes | 1.11 | 0.55-2.21 | | 0.82 | 0.49-1.35 | |
ASA score (%) | | | 0.30 | | | 0.47 |
<4 pts | 1.00 | - | | 1.00 | - | - |
4-5 pts | 0.52 | 0.15-1.81 | | 0.73 | 0.31-1.73 | |
Charlson group | | | 0.50 | | | 0.89 |
0-3 pts | 1.00 | - | | 1.00 | - | |
> = 4 pts | 1.44 | 0.50-4.11 | | 0.94 | 0.39-2.28 | |
Length of stay | | | 0.57 | | |
<0.001*
|
<20 days | 1.00 | - | - | 1.00 | - | - |
21-40 days | 0.86 | 0.26-2.92 | 0.81 | 2.75 | 1.52-4.96 | 0.001 |
> = 41 days | 1.75 | 0.59-5.17 | 0.31 | 2.89 | 1.41-5.92 | 0.004 |
Recent stay in intensive care | | | 0.59 | | |
0.04*
|
No | 1.00 | - | | 1.00 | - | |
Yes | 0.79 | 0.35-1.81 | | 1.83 | 1.03-3.24 | |
McCabe classification (%) | | | 0.84 | | |
0.14*
|
Non fatal | 1.00 | - | - | 1.00 | - | - |
Fatal within 5 years | 0.81 | 0.36-1.82 | 0.61 | 1.70 | 0.99-2.91 | 0.05 |
Fatal within 6 months | 1.11 | 0.31-4.04 | 0.87 | 0.98 | 0.32-3.00 | 0.98 |
Prior exposure to urinary catheter | | |
<0.001*
| | |
<0.001*
|
No | 1.00 | - | | 1.00 | - | |
Yes | 6.77 | 3.20-14.35 | | 3.04 | 1.83-5.04 | |
Hemiplegia | | |
0.08*
| | | 0.34 |
No | 1.00 | - | | 1.00 | - | |
Yes | 2.04 | 0.93-4.46 | | 1.36 | 0.73-2.54 | |
Immune suppression° | | | 0.39 | | | 0.57 |
No | 1.00 | - | | 1.00 | - | |
Yes | 1.55 | 0.57-4.18 | | 1.24 | 0.58-2.65 | |
UTI with and without prior UC exposure
In the model assessing the likelihood of UTI stratified on prior exposure to UC (Table
2), the only factor significantly associated was a prolonged hospital stay > 40 days, while female gender showed only a tendency for association. In the model stratified on no prior exposure to UC, female gender, hemiplegia, and a recent stay in intensive care all increased significantly the odds for UTI.
UTI stratified by gender
In the model assessing the likelihood of UTI stratified by gender (Table
3), prior exposure to UC was significantly associated with UTI for both, whereas the length of hospital stay was significantly associated with UTI for women, but not for men.
Exposure to UC
We investigated the variables associated with the use of UC after stratification by gender. There were no differences between genders according to exposure to UC. The following factors were independently associated with a higher odds for the use of UC: age >70 years; recent surgical intervention; ASA score > 4 points; Charlson index > 4 points; high McCabe classification; recent stay in intensive care; and hemiplegia.
Discussion
In this large study of patients hospitalised in Swiss acute care facilities, 25% were exposed to UC and 1.5% developed symptomatic UTI. Congruent with our results and other national and regional prevalence studies, a European report estimated a prevalence of nosocomial UTI of 1.65% (Table
4). Our findings mirror reports revealing a prevalence of UC use of 20.3% in emergency departments[
8], 32% to 36% in acute care wards[
5], and similar rates in most surveys conducted elsewhere (Table
4). The median duration of exposure to UC was also congruent with the literature, i.e., 2–4 days[
18-41].
Table 4
Prevalence of urinary catheter use and/or symptomatic healthcare-associated urinary tract infection: reports in the peer-reviewed literature (January 1980-December 2012)
| 40 hospitals in eight countries, n = 3899 | Point prevalence | 10.1% men, 11.8% women | 6.5% | Conducted in 1980 |
| 130 hospitals, n = 34,577 | Point prevalence | 9.4% | 2.1% | National prevalence survey in Italy, 1983 |
| 106 hospitals, n = 8723 | Point prevalence | 15.7% | 4.4% | National prevalence survey in Belgium 1984 70% surgery. Definition nosocomial: > 3rd day |
| 23 hospitals, n = 12,260 | Point prevalence | | 1.5% | Prevalence survey in Czechoslovakia, 1984 |
| 157 centres, n = 37,111 | Survey | - | 2.4% | Prevalence survey in UK and Ireland, 1994 |
Gastmeier et al.[ 24] 1997 | 72 hospitals, n = 14,966 | Point prevalence | | 1.1% | National prevalence survey in Germany, 1994 |
| All acute care hospitals, n = 12,755 | Point prevalence | - | 2.2% | National prevalence survey in Norway, 1997 |
| n = 51,674 in 1997 | Point prevalence | - | 2.1% | National prevalence surveys in Spain, 1990-1997 |
French Prevalence Group[ 27] 2000 | 830 hospitals, n = 236,334 | Point prevalence | 9.6% | 1.6% | National prevalence survey in France, 1996, including psychiatric and long-term care wards |
| Acute care hospitals, n = 11,500-12,500 | Point prevalence | - | 1.7-2.0% | National prevalence surveys in Norway, 2002 and 2003 |
| n = 3925 | Point prevalence | 8.6% | 2.1% | Survey in 14 Greek hospitals, 1999 |
| Public hospitals, n = 18,667 | Point prevalence | - | 1.6% | Prevalence survey in Lombardy, 2000 |
| Acute care, n = 6695 | Point prevalence | - | 1.2% | National prevalence survey in Slovenia, 2001 |
| 15 hospitals in Italy, n = 2165 | Point prevalence | 22.4% | 1.7% | All participating hospitals have > 400 beds |
| Surgery, n = 111,330 523 Medicare hospitals | Retrospective cohort study | 32% at discharge day | - | Patients at discharge after hip replacement |
| 31 hospitals, n = 6369 | | 16.5% | 1.65% | Acute hospitals and long-term care facilities in Sweden, 2002 |
| n = 5750 | Point prevalence | 22% | 3.4% | National prevalence survey in Canada, 2002 |
| 2 tertiary Dutch hospitals, n = 2661 | Point prevalence twice a year | - | 2.3% (1.2%-3.4%) | 2001-2004. Obstetric wards excluded |
| 445 US hospitals, n = 33,726,611 | Throughout the year 2002 | - | 1.3% | Estimations for the USA |
| 21 Italian hospitals, n = 6352 | Period prevalence | 25.2% | 2.2% | Prevalence study in Veneto region, Italy 2003 |
van den Broek et al.[ 37] 2011 | 10 hospitals, n = 16,495 | Period prevalence | 20.2% | 2.6% | Netherlands, acute care hospitals |
| 45 acute care hospitals, n = 11,090 | Point prevalence | 20.3% | 2.0% | Scotland 2006, exclusion of obstetric patients |
| 69 long-term care facilities, n = 4,170 | Point prevalence | 5.6% | 1.5% | Long-term care facilities in Ireland, June 2010 |
| 8 university hospitals, n = 3450 | Point prevalence | 23.1% | 1.4% | University hospitals in Shiraz, Iran |
Health Protection Agency[ 41] 2012 | 103 healthcare facilities, n = 52,443 | Point prevalence | 18.8% | 1.1% | English national point prevalence survey preliminary data |
Present article
| Acute care hospitals, n = 8169 | Period prevalence Cluster-adapted | 24% | 1.5% | National prevalence survey in Switzerland, 2004 |
By contrast, we are not able to compare healthcare-associated UTI prevalence with prevalence encountered in the community. Scientific data on the incidence or prevalence of UTI in the Swiss general population are non-existent, while the literature provides only data in predefined populations, such as elderly men or diabetic patients. Moreover, different survey studies define UTI differently, e.g., by excluding or including asymptomatic colonization. However, according to rough data, the overall life-long incidence of UTI could be around 2-4% for young males[
42], 6.3% for older Scandinavian males[
43], and up to 20% for females. Among Saudi diabetic males, the prevalence might be as high as 7%, whereas asymptomatic urinary tract colonization might be as high as 41% in diabetic women[
44].
We found a significant association between UTI and UC use. However, the relation between prior exposure to UC and subsequent UTI was much less systematic than expected, and UC use preceded UTI in only 58% of cases. This does not appear to be unique to our study. In a European study reviewing 4.4 million admissions in 1999, 37.2% of all UTI episodes did not reveal prior exposure to UC[
4]. A proportion of 41% UTI without prior exposure to UC has been similarly evidenced in Italian hospitals[
31], while Jespen et al. found 56.7% of patients with healthcare-associated UTI attributed to prior UC use[
19]. These reports did not further explore the relative low frequency of UC use prior to UTI.
In our study population, the low rate of UTI may reflect the low UC utilization rates. This is not surprising. One explanation might be recent surgery and/or a short ICU stay as these patients are often exposed to UC and acquire UTI more frequently than those hospitalised on medical wards. According to survey definitions, UC use was only recorded when it lasted > 24 h, but some patients undergoing surgery could have been exposed to UC for a shorter time, at least during surgery or ICU stay. Although it cannot be excluded that short duration catheterisation might predispose to subsequent UTI, this is unlikely given the low UTI incidence of only 2%[
45] to 2.5%[
46] at 24 h of UC use. Moreover, at least in the largest institution involved in the current study, this assumption would not be true[
47]. Since 2001, UC during surgery is restricted to patients with a foreseen duration of more than 5 h or for arthroplasty surgery if the patient meets one of the following conditions: age >75 years; ASA class >3 points; presence of morbid obesity or urinary incontinence[
43,
48]. Thus, only 15.7% of all orthopaedic surgery is performed with a UC in place. For postanaesthesia care, only 4.7% of all patients required bladder catheterisation without permanent insertion of a UC[
46].
Another population prone to intermittent catheterisation are patients with neurogenic bladders who were not identified as such in our study protocol[
49,
50]. Of note, our study involved acute care settings with the voluntary exclusion of long-term care facilities or homes where most patients with neurogenic bladders are usually housed. Thus, the prevalence of neurogenic bladders in acute care settings should be low. We consider that we have avoided a major bias by including paraplegic patients in the study population. Finally, the exact risk of symptomatic UTI after one single intermittent catheterisation is unknown. Most of the literature on intermittent catheterisation concerns individuals with repeated catheterisation due to neurologic problems[
49,
50]. Among these patients with intermittent self-catheterisation during several years or months, the cumulative risk of UTI is reported to be as high as 50% according to several surveys[
50]. However, these patients cannot be compared with individuals with normal bladders who are only undergoing one single intermittent catheterisation for anaesthesiological or surgical reasons.
UTI can complicate urological interventions and be technically classified as surgical site infection. In a literature review, Slade reported approximately 19% UTI after urological surgery[
48]. We are unable to provide information on the proportion of “official urological patients” among all those undergoing surgery, because many Swiss surgical wards are mixed, especially in smaller hospitals, are mixed and care for urology and non-urology patients at the same time. Similarly, the same surgeons may often perform urologic and other surgical interventions during the same day. However, it is unlikely that these urologic patients represent a large group and that freshly-operated urological patients would have been exposed to UC for more than 24 h. Specialized, urology-only, surgical wards did not exist in Switzerland at the time of the study and urology patients constitute a maximum of 10% of all surgical patients in many university centres. As summarised in Table
4, few national prevalence studies further stratify or report surgical specialties in detail. In the studies by Emmerson et al.[
23] and Sramova et al.[
22], the proportion of patients hospitalised on urological wards was only 3.9% and 2.4%, respectively.
Our survey has several limitations. i) The study design was not targeted towards delineating the origin of UTI. The causal inference between exposure to UC and UTI seems logical, but is not proven
sensu strictu. ii) Despite the large number of patients included, only 126 acquired UTI. Although positive in terms of infection control, these small numbers are associated with reduced statistical power that is recognized in the wide confidence intervals. iii) Results are limited to acute care sectors. Many patients exposed to UC in high-income countries live in nursing homes or other long-term care facilities where the prevalence is higher and UTI is one of the most frequent infections[
1,
10]. iv) Data related to antibiotic administration or urine acidification are lacking. This could be important as patients treated for other infections might be protected from UTI with antimicrobials covering Gram-negative rods, while antibiotic administration prior to hospital admission might equally have diminished the bacterial burden in the genitourinary system. To the best of our knowledge, no prevalence study has explored this theoretical relationship. Of note, in our study, symptomatic UTI occurred on average two weeks after hospital admission, but we ignore if patients already had asymptomatic urinary tract colonization before hospital admission. v) So far, only prevalence studies and personal clinical experience report a high proportion of UTI without prior exposure to UC. There are no prospective cohort studies or randomized trials to confirm this ubiquitous finding. We currently ignore if the ability to track the catheter as a risk factor for nosocomial UTI might be limited when using prevalence studies. vi) Our study protocol did not target differences in the clinical presentation between UTI with and without prior UC use. This may be a bias as the presence of UC may influence physicians in the work-up of fever, i.e., they might order urine cultures more often in patients with UC. This theoretical bias is likely to shift the proportion of UTI towards UC use.
In conclusion, exposure to UC is the most important risk factor for healthcare-associated UTI according to prevalence studies, but only for a proportion of all patients ── at best two-thirds. This finding appears to be shared by other local or national prevalence studies. In our study, the separate analysis for UTI in the absence of prior UC use revealed only female gender[
48], hemiplegia[
5], and prolonged hospital stay as significant risk factors. The cumulative impact of other less inalienable risk factors should not be underestimated. Further research needs to place an emphasis on innovative strategies to address the specific issues of UTI in the absence of exposure to UC.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
The national prevalence study was designed by all authors. The study was primarily coordinated by HS and IU with support from all authors, including identifying patients and collecting data on cases. IU, HS and AG managed the data and performed the initial analysis of cases. IU, AG, and DP drafted the manuscript. All authors interpreted the results and revised the manuscript.